New biomarkers may predict interstitial lung disease progression in patients with systemic sclerosisJune 16, 2021Autoimmune DiseasesRare Diseases
Lenabasum missed mark for systemic sclerosis but may show promise for adjunctive therapyJune 11, 2021Autoimmune DiseasesMedical Dermatology
Intravenous immunoglobulin controls dermatomyositis in phase 3 trialJune 3, 2021Autoimmune DiseasesMedical DermatologyRare Diseases
FDA panel narrowly backs avacopan approvalMay 7, 2021Autoimmune DiseasesMedical DermatologyRare Diseases
Black patients with cutaneous sarcoidosis may have more systemic and CV diseaseApril 15, 2021Autoimmune DiseasesDiversity in Medicine
COVID-19’s impact on lupus inpatients examined in studyMarch 24, 2021COVID-19 UpdatesAutoimmune DiseasesMedical Dermatology
Nearly 20% of lupus patients have severe infection in first decade after diagnosisMarch 11, 2021Infectious DiseasesAutoimmune DiseasesMedical Dermatology
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquineMarch 2, 2021PediatricsAutoimmune DiseasesMedical Dermatology
Consider home subcutaneous immune globulin for refractory dermatomyositisFebruary 17, 2021Medical DermatologyAutoimmune Diseases
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseasesFebruary 16, 2021MelanomaAutoimmune Diseases
Meta-analysis finds much less lupus than expectedJanuary 29, 2021Autoimmune DiseasesMedical Dermatology
Severe renal arteriosclerosis may indicate cardiovascular risk in lupus nephritisJanuary 22, 2021Autoimmune DiseasesMedical Dermatology
High hydroxychloroquine blood level may lower thrombosis risk in lupusJanuary 6, 2021Autoimmune DiseasesMedical Dermatology
